We are delighted to announce that our electronic National Residential Medication Chart (eNRMC) product, emma, has been approved by the Tasmanian Government for use as a transitional eNRMC. This approval demonstrates our commitment to providing innovative solutions that meet the highest standards of safety and efficacy in medication management.
emma eNRMC is a user-friendly electronic medication management system designed to streamline medication administration in residential care facilities. It is an essential tool for ensuring medication safety and reducing the risk of errors. The following are some of the benefits of emma eNRMC:
Improved accuracy and efficiency: emma reduce the risk of medication errors by providing accurate and up-to-date information on medication administration. emma also simplifies the medication ordering and dispensing process, reducing the time and effort required for these tasks.
Enhanced communication and collaboration: emma enables healthcare professionals to collaborate more effectively by providing a centralized platform for medication management. This facilitates better communication between healthcare providers, improving patient outcomes.
Safety: emma improves patient safety by ensuring that medication lists are accurate and up-to-date, thereby reducing the risk of medication errors. Healthcare professionals save time in medication reconciliation, which traditionally involves a time-consuming manual review of multiple sources of information.
Enhanced compliance: emma ensures compliance with legal and regulatory requirements. It also provides a clear audit trail of medication administration and prescribing, making it easier to track and manage medication-related incidents.
With emma eNRMC we look forward to partnering with healthcare providers across Tasmania to improve medication management and enhance patient care